Cargando…
Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
OBJECTIVE: Leucine-rich α-2 glycoprotein 1 (LRG1) was recently identified as an amplifier of transforming growth factor-β (TGF-β)–induced kidney fibrosis in animal models. We aimed to study whether urine LRG1 is associated with risk of progression to end-stage kidney disease (ESKD) in individuals wi...
Autores principales: | Liu, Jian-Jun, Liu, Sylvia, Wang, Jiexun, Pek, Sharon L.T., Lee, Janus, Gurung, Resham L., Ang, Keven, Shao, Yi Ming, Tavintharan, Subramaniam, Tang, Wern Ee, Sum, Chee Fang, Lim, Su Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887617/ https://www.ncbi.nlm.nih.gov/pubmed/36516193 http://dx.doi.org/10.2337/dc22-1611 |
Ejemplares similares
-
A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions
por: Liu, Chenghao, et al.
Publicado: (2020) -
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes
por: Vaisar, Tomas, et al.
Publicado: (2018) -
Relationship Between Fasting Plasma Glucagon Level and Renal Function—A Cross-Sectional Study in Individuals With Type 2 Diabetes
por: Liu, Jian-Jun, et al.
Publicado: (2018) -
Experimental modeling of cornea wound healing in diabetes: clinical applications and beyond
por: Bu, Yashan, et al.
Publicado: (2019) -
Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)